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Abstract
Introduction: There are few data related to the effects of different sources of infection on outcome. We used the
Sepsis Occurrence in Acutely ill Patients (SOAP) database to investigate differences in the impact of respiratory tract
and abdominal sites of infection on organ failure and survival.
Methods: The SOAP study was a cohort, multicenter, observational study which included data from all adult
patients admitted to one of 198 participating intensive care units (ICUs) from 24 European countries during the
study period. In this substudy, patients were divided into two groups depending on whether, on admission, they
had abdominal infection but no respiratory infection or respiratory infection but no abdominal infection. The two
groups were compared with respect to patient and infection-related characteristics, organ failure patterns, and
outcomes.
Results: Of the 3,147 patients in the SOAP database, 777 (25%) patients had sepsis on ICU admission; 162 (21%)
had abdominal infection without concurrent respiratory infection and 380 (49%) had respiratory infection without
concurrent abdominal infection. Age, sex, and severity scores were similar in the two groups. On admission, septic
shock was more common in patients with abdominal infection (40.1% vs. 29.5%, P = 0.016) who were also more
likely to have early coagulation failure (17.3% vs. 9.5%, P = 0.01) and acute renal failure (38.3% vs. 29.5%, P = 0.045).
In contrast, patients with respiratory infection were more likely to have early neurological failure (30.5% vs. 9.9%,
P < 0.001). The median length of ICU stay was the same in the two groups, but the median length of hospital stay
was longer in patients with abdominal than in those with respiratory infection (27 vs. 20 days, P = 0.02). ICU (29%)
and hospital (38%) mortality rates were identical in the two groups.
Conclusions: There are important differences in patient profiles related to the site of infection; however, mortality
rates in these two groups of patients are identical.
Introduction
Infection is a major challenge in the intensive care unit
(ICU). Cited prevalence rates of ICU infection vary
between 45% to 58% [1,2], and incidence rates between
30% to 35% [3,4]. Infections are already present on
admission to the ICU in about 50% of cases; rates are
perhaps even higher in studies limited to critically ill
patients [1-6].
It has been shown that infections originating from the
urinary tract usually have a better outcome than infec-
tions from other sources [7-10]. However, whether there
are differences in outcomes for other sources of sepsis is
not well defined. Lung and abdominal infections are the
most common infections in the ICU [3,4,6,11], and sev-
eral studies have suggested that, although respiratory
infections are more common, abdominal infections may
be more severe [3,10,12-15]. However, whether this
translates into worse outcomes is unclear. Importantly,
if outcomes vary according to the source of infection,
this may impact on clinical trial design, as currently
patients with infections from different sources are often
grouped together.
The aim of the present study was, therefore, to inves-
tigate whether the presence at ICU admission of infec-
tions originating in these two sites, abdomen and lung,
had any impact on patterns of organ failure or on
patient outcome. For this purpose, we used the database
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study [6], a large systematic cohort study performed in
European ICU patients.
Materials and methods
Study design
The SOAP study was a prospective multicenter observa-
tional study designed to evaluate the epidemiology and
characteristics of sepsis in European countries and was
initiated by a working group of the European Society of
Intensive Care Medicine. Full details of recruitment,
data collection and management have been provided
elsewhere [6]. Briefly, all adult patients (> 15 years old)
admitted to a participating center (see Additional file 1
for a list of participating countries and centers) between
1 and 15 May 2002 were included, except patients who
stayed in the ICU for less than 24 hours for routine
postoperative surveillance. Due to the observational
character of the study which did not require any devia-
tion from routine medical care, institutional review
board approval was either waived or expedited in parti-
cipating institutions and informed consent was not
required. Patients were followed up until death, hospital
discharge, or for 60 days.
Data collection and management
Data were collected prospectively using pre-printed case
report forms and entered centrally by medical personnel.
Data collection on ICU admission included demographic
data, comorbid diseases, admission category, source of
admission and admission diagnosis. Clinical and labora-
tory data needed to calculate the Simplified Acute Phy-
siology Score II (SAPS II) were reported as the worst
value within 24 hours after hospital admission [16]. Eva-
luation of organ function was made using the Sequential
Organ Failure Assessment (SOFA) score, based on the
most abnormal value for each of the six organ systems
[17]. Daily collection of data included infection charac-
teristics, organ function and the need for special suppor-
tive modalities such as mechanical ventilation,
hemofiltration and hemodialysis.
Definitions
Infection was defined as the presence of a pathogenic
microorganism in a sterile milieu and/or clinically sus-
pected infection, plus the administration of antibiotics.
Clinically suspected infection was diagnosed at the dis-
cretion of the attending physician. Sepsis and severe
sepsis and septic shock were defined by standard criteria
[18]. Organ failure was defined as a Sequential Organ
Failure Assessment (SOFA) score > 2 for the organ in
question [17]. Early organ failure and late organ failure
were defined as those occurring within and after
48 hours of a diagnosis of sepsis, respectively. For the
purposes of this substudy, two groups were identified:
Patients with abdominal infection (microbiologically
proven or clinical diagnosis) on admission to the ICU
without any concurrent respiratory infection and those
with respiratory infections (microbiologically proven or
clinical diagnosis) on ICU admission without concurrent
abdominal infection. Secondary infections were defined
as infections occurring more than 24 hours after onset
of a preexisting infection, at a site other than the
abdominal or respiratory system for patients in the
abdominal or respiratory groups, respectively.
Statistical analysis
Data were analyzed using the Statistical Package for
Social Sciences (SPSS) for Windows, version 17.0 (SPSS
Inc., Chicago, IL, USA). A Kolmogorov-Smirnov test
was used, and histograms and normal-quantile plots
were examined to verify the normality of distribution of
continuous variables. Discrete variables are expressed as
counts (percentage) and continuous variables as means
± SD or median (25th to 75th percentiles). For demo-
graphic and clinical characteristics of the study groups,
differences between groups were assessed using a chi-
square, Fisher’s exact test, Student’s t-test or Mann-
Whitney U test, as appropriate. We performed a multi-
variate logistic regression analysis with development of
secondary infection as the dependent factor to investi-
gate the influence of length of ICU stay on the develop-
ment of secondary infection in abdominal and
respiratory groups. Variables considered for the analysis
included, demographic data, co-morbidities, SAPS II
score on admission, type of microorganism, organ fail-
ure assessed by the SOFA score. Only variables asso-
ciated with a higher risk of development of secondary
infection (P < 0.2) on a univariate basis were modeled.
All variables included in the model were tested for coli-
nearity. Interaction terms involving combinations
between length of ICU stay and presence in the abdom-
inal or respiratory group were tested. A Hosmer and
Lemeshow goodness of fit test was performed and odds
ratios and their corresponding 95% confidence intervals
were calculated [19]. We also performed a multivariate
Cox proportional hazard model with time to in-hospital
death as the dependent factor. Variables included in the
Cox regression analysis were: age, gender, comorbid dis-
eases, SAPS II and SOFA scores on admission, the type
of admission (medical or surgical), source of admission,
admission diagnosis, the presence of sepsis, early organ
failure, and the need for mechanical ventilation or renal
replacement therapy during the ICU stay. Variables
were introduced in the model if significantly associated
with a higher risk of in-hospital death on a univariate
basis at a P-value < 0.2. Colinearity between variables
was excluded prior to modeling. The time dependent
covariate method was used to check the proportional
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hazard assumption of the model; an extended Cox
model was constructed, adding interaction terms that
involve time, that is, time dependent variables, com-
puted as the by-product of time and individual covari-
ates in the model (time × covariate). Individual time-
dependent covariates were introduced one by one and
in combinations in the extended model, none of which
was found to be significant. A stepwise approach was
used and presence in the abdominal or respiratory
group variable was forced as the last step in the model.
A Kaplan-Meier survival analysis was performed and
survival between groups was compared using a Log rank
Test. All statistics were two-tailed and a P < 0.05 was
considered to be statistically significant.
Results
Study population
Of the 3,147 patients enrolled in the SOAP study, 777
(25%) had sepsis on admission to the ICU; of these, 162
(21%) had abdominal infection without concurrent
respiratory infection and 380 (49%) had respiratory
infection without concurrent abdominal infection. The
baseline characteristics of the patients are summarized
in Table 1. Age, sex, SAPS II and SOFA scores were
similar in the two groups. Patients with abdominal
infections were more likely to be surgical admissions
and to have been referred from the operating room or
recovery room; they were more likely than patients with
respiratory infections to have cancer but less likely to
have chronic obstructive pulmonary disease (COPD) or
hematologic cancer. Patients with respiratory infection
were admitted mainly because of respiratory (57%), car-
diovascular (19%) and neurologic diagnoses (13%), while
patients with abdominal infection were primarily
admitted because of digestive/liver (40%) and cardiovas-
cular diagnoses (34%).
Infection-related characteristics
Table 2 shows the major microbiological data. Micro-
biologic cultures were positive in 46% of the patients.
Diagnostic criteria for infection and the overall rates of
Gram-positive, Gram-negative, or fungal infection were
similar in the two groups. The most commonly isolated
organisms in patients with abdominal infections were
Staphylococcus aureus and Streptococcus group D, and
in patients with respiratory infections, the most com-
monly isolated organisms were S. aureus and Pseudomo-
nas species. Streptococcus pneumoniae infections were
more common in patients with respiratory than in those
with abdominal infections (4.7% vs. 0.6%, P = 0.02),
while Streptococcus group D (18.5% vs. 6.3%, P < 0.001)
and any streptococcal (24.1% vs. 12.9%, P < 0.001) infec-
tions were more common in patients with abdominal
infections. Escherichia coli (15.4% vs. 7.6%, P = 0.006)
and Candida non-albicans (6.2% vs. 2.4%, P = 0.027)
infections were also more common in patients with
abdominal infections than in those with respiratory
infections.
Secondary infections were more common in patients
with abdominal infections (70 patients, 43%), than in
those with respiratory infections (119 patients, 31%),
P = 0.010. Thirty-five patients (22%) with abdominal
infections developed respiratory infections later during
the ICU stay and 15 patients (4%) with respiratory infec-
tions developed abdominal infections (Table 3). Patients
with abdominal infection on admission were more likely
to develop secondary skin/wound infection (16% vs.
5.5%, P < 0.001) whereas patients with respiratory infec-
tions were more likely to develop secondary urinary
infections (9.2% vs. 1.9%, P < 0.001). Patients in the
abdominal group who developed secondary infections
had a longer ICU stay than those who did not (12 (5.7
to 27.3) days versus 9.8 (4.6 to 21.9), P < 0.05). Multiple
logistic regression analysis showed that the relationship
between the abdominal group and the development of
secondary infection was related to ICU stay (interaction
parameter = 0.069, P = 0.011 (Table 4). Specifically, the
odds ratio of developing secondary infections increased
with increasing duration of ICU stay in the abdominal
group (Figure 1).
Morbidity and mortality
Although the incidence of severe sepsis on admission
was similar in the two groups (around 70%), more
patients with abdominal infection had septic shock on
admission than patients with respiratory infection
(40.1% vs. 29.5%, P = 0.016). However, when considering
the incidence of sepsis syndromes during the whole ICU
stay, these differences lost statistical significance
(Table 5).
Patients with abdominal infection also had a greater
incidence of early coagulation failure (17.3% vs. 9.5%,
P = 0.01) and early acute renal failure (38.3% vs. 29.5%,
P = 0.04), and more needed hemofiltration than patients
with respiratory infection. Patients with respiratory
infection were more likely to have early neurological
failure than patients with abdominal infection (30.5% vs.
9.9%, P < 0.001).
The median duration of ICU stay was the same in the
two groups, but the median duration of hospital stay
was longer for patients with abdominal infection (27
days vs. 20 days, P = 0.02). ICU (29.0% vs. 28.9%) and
hospital (37.5% vs. 38.1%) mortality rates were remark-
ably similar in the two groups of patients. In a Kaplan
Meier survival analysis, 60-day survival was similar
between groups (Log Rank = 0.267, P = 0.605; Figure 2).
In Cox regression analysis (Table 6), age, cancer, septic
shock on admission, early coagulation failure, acute
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renal failure, and neurological failure were all associated
with an increased risk of death, but abdominal or
respiratory infection were not.
Discussion
Using data from a large, prospective, pan-European
database, we investigated the impact on organ failure
and survival of the presence on admission of infection
at two of the most common sites, the lung and the
abdomen. On admission, patients with abdominal infec-
tion were more likely to have septic shock, early coagu-
lation failure and early acute renal failure, and more
needed hemofiltration than patients with respiratory
infection. In contrast, patients with respiratory infections
were more likely to have concurrent early neurological
dysfunction than patients with abdominal infection.
Table 1 Baseline characteristics and outcomes
Characteristic All patients
(n = 542)
Abdominal infection
(n = 162)
Respiratory infection
(n = 380)
P-value
Age, years 63.2 ± 15.7 65.1 ± 15.0 62.4 ± 16.0 0.11
Male 314 (58.4%) 89 (55.3%) 225 (59.7%) 0.34
SAPS II score 43.6 ± 17.1 43.1 ± 17.7 43.9 ± 16.8 0.42
SOFA score 6.5 ± 4.1 6.4 ± 4.0 6.6 ± 4.2 0.65
Co-morbidities
Cancer 79 (14.6%) 34 (21.0%) 45 (11.8%) 0.006
Hematologic cancer 26 (4.8%) 2 (1.2%) 24 (6.3%) 0.01
COPD 107 (19.7%) 19 (11.7%) 88 (23.2%) 0.002
Cirrhosis 26 (4.8%) 10 (6.2%) 16 (4.2%) 0.32
HIV and/or AIDS 7 (1.3%) 0 7 (1.8%) 0.10
Heart failure 42 (7.7%) 8 (4.9%) 34 (8.9%) 0.11
Diabetes 35 (6.5%) 9 (5.6%) 26 (6.8%) 0.57
Admission category
Medical 333 (61.4%) 32 (19.8%) 301 (79.2%) < 0.001
Surgical 209 (38.6%) 130 (80.2%) 79 (20.8%) < 0.001
Elective 82 (15.1%) 35 (21.6%) 47 (12.4%)
Emergency 127 (23.4%) 95 (58.6%) 32 (8.4%)
Source of admission < 0.001
ER/Ambulance 118 (24.0%) 17 (11.6%) 101 (29.3%)
Hospital floor 191 (38.9%) 40 (27.4%) 151 (43.8%)
OR/Recovery 126 (25.7%) 82 (56.2%) 44 (12.8%)
Hospital other 56 (11.4%) 7 (4.8%) 49 (14.2%)
Admission diagnosis < 0.001
Monitoring 15 (2.8%) 7 (4.5%) 8 (2.1%)
Neurologic 51 (9.5%) 3 (1.9%) 48 (12.7%)
Respiratory 229 (42.8%) 15 (9.6%) 214 (56.6%)
Cardiovascular 123 (23.0%) 53 (33.8%) 70 (18.5%)
Renal 14 (2.6%) 9 (5.7%) 5 (1.3%)
Digestive/liver 73 (13.6%) 63 (40.1%) 10 (2.6%)
Trauma 16 (3.0%) 4 (2.5%) 12 (3.2%)
Others 14 (2.7%) 3 (2.0%) 11 (2.9%)
Sepsis syndromes
Severe sepsis 391 (72.1%) 113 (69.8%) 278 (73.2%) 0.41
Septic shock 177 (32.7%) 65 (40.1%) 112 (29.5%) 0.01
Length of ICU stay (days) 6 (3 - 13) 6 (2 - 15) 6 (3 - 13) 0.95
Length of hospital stay (days) 21 (10 - 44) 27 (13 - 48) 20 (10 - 41) 0.02
ICU mortality 157 (29.0%) 47 (29.0%) 110 (28.9%) 0.98
Hospital mortality 204 (37.6%) 60 (37.5%) 144 (38.1%) 0.89
Data are expressed as mean ± standard deviation, number (percentage), or median (interquartile range). AIDS: acquired immune deficiency syndrome; COPD:
chronic obstructive pulmonary disease; ER: emergency room; HIV: human immunodeficiency virus; ICU: intensive care unit; OR: operating room; SAPS II: Simplified
Acute Physiology Score; SOFA: Sequential Organ Failure Assessment
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However, the median length of ICU stay was the same
in the two groups and the two groups had identical ICU
and hospital mortality rates.
The present study focused on infections originating
from the lungs and the abdomen, because these two
sites represent the most common causes of infection in
acutely ill patients [3,4,6,11], and are also associated
with higher workload and increased costs compared to
other infections [20]. On admission, 49% of patients
with sepsis had respiratory infections and 21% abdom-
inal; overall in the SOAP study, 68% of patients had
respiratory and 22% abdominal infections [6]. Similarly,
in a study of 5,878 patients from Australia and New
Zealand, the site of infection was pulmonary in 50% and
abdominal in 19% of the episodes [11]. In another Eur-
opean study of 14,364 patients, the lung contributed to
62% of infections and intra-abdominal infections to 15%
[3].
Table 2 Diagnostic criteria for infection and the microorganisms isolated in patients with abdominal and respiratory
infections
Characteristic All patients
(n = 542)
Abdominal infection
(n = 162)
Respiratory infection
(n = 380)
P-value
Diagnostic criteria
Isolates only 44 (8.1%) 9 (5.6%) 35 (9.2%) 0.17
Clinical only 294 (54.2%) 91 (56.2%) 203 (53.4%) 0.57
Both 204 (37.6%) 62 (38.3%) 142 (37.4%) 0.85
Class/microorganism
Gram-positive 130 (23.9%) 42 (25.9%) 88 (23.2%) 0.58
Gram-negative 144 (26.5%) 43 (26.5%) 101 (26.6%) 0.64
Anaerobes 9 (1.6%) 7 (4.3%) 2 (0.5%) 0.45
Atypical microorganisms 4 (0.7%) 0 4 (1.1%) 0.323
Fungi 81 (14.9%) 30 (18.5%) 51 (13.4%) 0.148
Gram-positive
Any Staphylococcus 119 (22.0%) 36 (22.2%) 83 (21.8%) 0.92
Staphylococcus aureus 91 (16.8%) 30 (18.5%) 61 (16.1%) 0.48
MRSA 59 (10.9%) 22 (13.6%) 37 (9.7%) 0.18
Staphylococcus, others 70 (12.9%) 19 (11.7%) 51 (13.4%) 0.59
Any Streptococcus 88 (16.2%) 39 (24.1%) 49 (12.9%) < 0.001
Streptococcus group D 54 (10.0%) 30 (18.5%) 24 (6.3%) < 0.001
Streptococcus pneumoniae 19 (3.5%) 1 (0.6%) 18 (4.7%) 0.02
Streptococcus, others 19 (3.5%) 9 (5.6%) 10 (2.6%) 0.09
Gram-positive bacilli 15 (2.8%) 3 (1.9%) 12 (3.2%) 0.57
Gram-positive, others 10 (1.8%) 1 (0.6%) 9 (2.4%) 0.29
Gram-negative
Pseudomonas species 67 (12.4%) 19 (11.7%) 48 (12.6%) 0.77
Escherichia coli 54 (10.0%) 25 (15.4%) 29 (7.6%) 0.006
Enterobacter 25 (4.6%) 11 (6.8%) 14 (3.7%) 0.11
Klebsiella 25 (4.6%) 6 (3.7%) 19 (5.0%) 0.51
Proteus 15 (2.8%) 6 (3.7%) 9 (2.4%) 0.38
Acinetobacter 17 (3.1%) 2 (1.2%) 15 (3.9%) 0.11
Haemophilus 12 (2.2%) 1 (0.6%) 11 (2.9%) 0.12
Gram-negative bacilli 36 (6.6%) 12 (7.4%) 24 (6.3%) 0.64
Gram-negative, others 90 (16.6%) 26 (16.0%) 64 (16.8) 0.82
Fungi
Candida albicans 61 (11.3%) 21 (13.0%) 40 (10.5%) 0.41
Candida, others 19 (3.5%) 10 (6.2%) 9 (2.4%) 0.02
Fungi, others 7 (1.3%) 2 (1.2%) 5 (1.3%) 1
Viral/parasitic 9 (1.7%) 1 (0.6%) 8 (2.1%) 0.21
CSF: cerebrospinal fluid; MRSA: methicillin-resistant S. aureus; Staphylococcus, others includes methicillin-sensitive S. aureus and Staphylococcus coagulase negative
methicillin-sensitive; Streptococcus, others includes Streptococcus A, B, C, G group and others; Gram-positive bacilli includes, Moraxella and others; Gram-negative,
others includes Salmonella, Serratia, Citrobacter, Stenotrophomonas maltophilia, Campylobacter, other enterobacteroids, Gram-negative cocci; Anaerobes includes
Clostridium, Bacteroides, anaerobic cocci, and others; Atypical microorganisms includes Mycobacteria, Chlamydia, Rickettsia, Legionella pneumonia; Fungi, others
includes Aspergillus and others. The microorganism was considered once per patient even if present in more than one site.
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Although respiratory infections are more common,
several studies have suggested that abdominal infec-
tions may be more severe [3,10,12-15]. The present
study supports these findings, as more patients with
abdominal infections than with respiratory infections
had septic shock on admission. Nevertheless, mortality
rates were similar in patients with abdominal and
those with respiratory infections. The association
between respiratory infection and a higher incidence of
early neurological failure may be because respiratory
infections are more common in patients with altered
mental status or neurological diagnoses [21-23]; in our
study, there was a higher proportion of neurological
diagnoses in patients with respiratory infections than
in those with abdominal infections. Moreover,
although the assumed Glasgow coma score is supposed
to be used for the SOFA score, it is possible that neu-
rological dysfunction may have been overestimated in
sedated patients. The association between abdominal
infections and coagulation failure may be related to
the fact that more patients with abdominal infections
had septic shock, which frequently provokes coagula-
tion abnormalities [24], or by the fact that most of
these patients were postoperative, as surgery may be
associated with altered coagulation [25,26]. However,
all these suggestions remain speculative as our study
design does not allow us to determine the reasons
underlying these associations.
It has been fairly consistently reported that secondary
infections are more frequent among patients who are
already infected when admitted to the ICU, but differ-
ences in definitions make it difficult to compare studies
[3,4,13,27,28]. Alberti et al. [3] reported that 26% of
patients who were infected on ICU admission developed
secondary infections compared to 15% of patients not
infected on admission. Malacarne et al. [4] reported that
23% of patients admitted with infections developed sec-
ondary infections compared to 9% of those who were
admitted without infection. Agarwal et al. reported that
infection on admission was an independent risk factor
for developing an ICU-acquired infection [27]. However,
the above studies focused on patients admitted with any
infection without distinguishing the type. In our study,
secondary infections occurred more commonly in
patients admitted with abdominal than with respiratory
infection, related to their longer ICU stay as shown by
the multivariate analysis. These patients also had a
higher incidence of skin/wound infections compared to
respiratory patients, likely related to more surgical
wound infections. Merlino et al. [28], in a retrospective
study of 168 patients with serious intra-abdominal infec-
tions, reported that 66 patients (40%) developed a
Table 3 Type of secondary infections
Abdominal infection Respiratory infection P-
value
Respiratory 35 (21.6%) NA -
Abdominal NA 15 (3.9%) -
Skin/wound 26 (16.0%) 21 (5.5%) < 0.001
Other 15 (9.3%) 27 (7.1%) 0.39
Unknown 4 (2.5%) 5 (1.3%) 0.46
Bloodstream 28 (17.3%) 48 (12.6%) 0.15
Urinary 3 (1.9%) 35 (9.2%) < 0.001
Catheter 14 (8.6%) 20 (5.3%) 0.14
CSF 0 2 (0.5%) 1
NA: not applicable
Table 4 Multiple logistic regression analysis in patients with abdominal infections. The development of secondary
infection was the dependent variable
Estimated coefficient SD Odds ratio (95% CI) P-value
SAPS II score, per point 0.016 0.006 1.016 (1.005 to 1.028) 0.005
ICU length of stay, per day 0.055 0.011 1.057 (1.034 to 1.079) < 0.001
Abdominal/respiratory variable
Respiratory infection Reference
Abdominal infection -0.076 0.316 0.927 (0.499 to 1.721) 0.810
Abdominal/respiratory infection by ICU LOS 0.069 0.027 1.071 (1.016 to 1.129) 0.011
CI: confidence interval; SD: standard error of the estimate; Hosmer and Lemeshow Chi square 7.636, P = 0.470. The percentage of correct classifications is 71.4.
Figure 1 The odds ratios of developing secondary infection in
the abdominal group for different durations of ICU stay. The
solid line represents the point of significance; ICU stays longer than
seven days were associated with a significant risk of developing
secondary infection.
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secondary nosocomial infection. The presence of sec-
ondary infections is associated with an increased length
of stay [29], but the effect of secondary infections on
mortality is controversial, because patients who develop
secondary infections are generally sicker and more likely
to die [2-7,27,30].
Interestingly, there were no differences in ICU (29%)
or hospital (38%) mortality between the two groups
despite the greater incidence of septic shock on admis-
sion in patients with abdominal infections. Mortality
rates in studies of infection and sepsis in the ICU are
quite variable. In studies in surgical ICUs, ICU mortality
rates in patients with abdominal infections varied from
22% to 72% [13-15,28,31-33]. ICU mortality rates for
patients with community-acquired pneumonia range
from 32% to 49% [22,34-36], and are perhaps higher in
patients with hospital-acquired pneumonia [37].
Table 5 Organ dysfunction patterns
Characteristic All patients
(n = 542)
Abdominal infection
(n = 162)
Respiratory infection
(n = 380)
P-value
Sepsis syndromes at any time during the ICU stay
Severe sepsis 449 (82.8%) 128 (79.0%) 321 (84.5%) 0.12
Septic shock 241 (44.5%) 81 (50.0%) 160 (42.1%) 0.09
Procedures during ICU stay
Mechanical ventilation 437 (80.6%) 129 (79.6%) 308 (81.1%) 0.70
Hemofiltration 69 (12.7%) 29 (17.9%) 40 (10.5%) 0.02
Hemodialysis 27 (5.0%) 8 (4.9%) 19 (5.0%) 0.97
SOFA scores
SOFA max 8.4 ± 4.4 8.4 ± 4.8 8.4 ± 4.3 0.90
SOFA mean 5.6 ± 3.9 5.6 ± 4.0 5.6 ± 3.9 0.95
Early organ failurea
Renal 174 (32.1%) 62 (38.3%) 112 (29.5%) 0.04
Respiratory 286 (52.8%) 79 (48.8%) 207 (54.5%) 0.22
Coagulation 64 (11.8%) 28 (17.3%) 36 (9.5%) 0.01
Hepatic 33 (6.1%) 7 (4.3%) 26 (6.8%) 0.26
CNS 132 (24.4%) 16 (9.9%) 116 (30.5%) < 0.001
Cardiovascular 249 (45.9%) 90 (55.6%) 159 (41.8%) 0.003
Late organ failureb
Renal 74 (13.7%) 16 (9.9%) 58 (15.3%) 0.09
Respiratory 56 (10.3%) 17 (10.5%) 39 (10.3%) 0.93
Coagulation 16 (3.0%) 7 (4.3%) 9 (2.4%) 0.21
Hepatic 16 (3.0%) 8 (4.9%) 8 (2.1%) 0.07
CNS 27 (5.0%) 8 (4.9%) 19 (5.0%) 0.97
Cardiovascular 30 (5.5%) 6 (3.7%) 24 (6.3%) 0.22
Organ failure any time
Renal 248 (45.8%) 78 (48.1%) 170 (44.7%) 0.46
Respiratory 342 (63.1%) 96 (59.3%) 246 (64.7%) 0.22
Coagulation 80 (14.8%) 35 (21.6%) 45 (11.8%) 0.003
Hepatic 49 (9.0%) 15 (9.3%) 34 (8.9%) 0.90
CNS 159 (29.3%) 24 (14.8%) 135 (35.5%) < 0.001
Cardiovascular 279 (51.5%) 96 (59.3%) 183 (48.2%) 0.01
CNS: Central nervous system; a, occurring within 48 hours of a diagnosis of sepsis;
b, occurring more than 48 hours after a diagnosis of sepsis
Figure 2 Kaplan-Meier survival curves representing 60-day
survival in patients with respiratory and those with abdominal
infection. Log Rank = 0.267: P = 0.605.
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Malacarne and colleagues found that among different
sites of infection, only peritonitis diagnosed during the
ICU stay was an independent prognostic factor for hos-
pital mortality (OR 3.4, P = 0.0021) [4]. Although in our
study, ICU lengths of stay were similar, the hospital
length of stay was longer in patients with abdominal
infection than in those with respiratory infection. We
can speculate that this may be due to differences in
baseline characteristics and the surgical nature of
abdominal infections which can require more prolonged
periods for resolution.
The advantage of our study is that it involves a large
database from multiple centers with systematic collection
of data. One limitation of the study is that the diagnoses
of abdominal and respiratory infections were made at the
discretion of the attending physician and criteria may
have varied slightly from one center to another. As part
of an observational study with a waiver of informed con-
sent, we were unable to perform invasive tests to obtain
more specific diagnoses and had to rely on what was rou-
tine clinical practice in the participating centers. In addi-
tion, we were unable to distinguish between hospital-
and community-acquired infections. Moreover, septic
shock was defined as the presence of infection plus the
need for vasopressor agents, according to standard cri-
teria at the time of the study. However, particularly in
surgical patients, vasopressors may be required as a result
of anesthetic agents, epidural anesthesia, blood loss, and
so on, so that in the presence of infection it may be diffi-
cult to accurately distinguish the specific reason for vaso-
pressor agents, thus confounding the diagnosis.
Moreover, there were some differences in patient charac-
teristics among the two groups of patients, but the multi-
variate analysis we performed adjusted for a large
number of these and other variables which are known to
influence outcome prediction.
Conclusions
This analysis revealed that the two most common
sources of infection on admission to the ICU are
associated with different profiles. Patients with abdom-
inal infection on admission are more likely to have sep-
tic shock on admission and to have early renal and
coagulation failure, whereas patients with respiratory
infection more commonly have early alteration in neu-
rological function. The length of hospital stay in patients
with abdominal infection is longer, likely because of the
increased numbers of secondary infections in these
patients. However, mortality rates were identical in the
two groups of patients. These observations outline inter-
esting differences depending on the source of sepsis,
which may have important implications for our under-
standing of the epidemiology of sepsis and in the con-
duct of clinical trials.
Key messages
• ICU patients admitted with abdominal infections
have different profiles compared to those admitted
with respiratory infections.
• ICU patients admitted with abdominal infections
had longer hospital lengths of stay and increased
numbers of secondary infections compared to
patients admitted with respiratory infections.
• However, ICU and hospital mortality rates were
the same regardless of the source of sepsis.
Additional file 1: Participants by country (listed alphabetically). A
Word file containing a list of participants by country, in alphabetical
order.
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